The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Maybe news on IB Zero G re submission
This week, annual accounts, shareholders letterš and PRD , which was resubmitted on the 16/2, best of luck to shareholders!
Cautious
Totally agree we are at this sp due to all the shenanigans but what I am trying to say is there must be an exit strategy by TB and no way is that at this valuation. He must know more about what is in the pipeline. As I keep saying this company must be or will be on bigger fishās radar. TB is looking at a paper loss of Ā£10m from what was the high point of 20p+. I think we have to be looking at a figure above that for him to sell.
Regarding KS and her involvement in other trials. It doesnāt mention IB but I would guess that they are using our technology for the imagery. The more other universities use our technology the better. Keep spreading the word etc.
Thanks
Could not agree more Cautious, I have no confidence in the board.
Anyway this might be of interest to those following the research work. Kathleen Schmainda is involved in a clinical trial. Interesting is no mention of IB, just MCW.
Here is the link. If you search for eaf223/gable and filter the results to the last week you get a few results with quite a lot of detail. It does fit in to one of the video presentations when they were discussing future work.
https://blog-ecog-acrin.org/now-enrolling-eaf223-gable-for-patients-with-glioblastoma/
The clinical trial reference is NCT06319027.
Financial results should be week after next, looking forward to seeing the figures.
Have a good weekend all
Shrek
Tyke the only reason the share price is were it is, is because TB ran it down to line his pockets, nothing to do with the quality of the company. He can come up with as many excuses has he wants but the truth is he his a manipulative little w.nker who is only interested in his own pocket and doesnāt give a f.ck about piās. That said he can only keep a good company down for so long, eventually the qualility will come through
It is 2 months since the last update. So the question is will TB want some good news published before the yearly results or the AGM? It will be interesting how he conveys what has happened to the share price after saying last year it was way undervalued and would try to improve upon it. Would he admit he has failed or will he try to increase the sp before then? Letās see what happens over the next few weeks or month.
Thanks
So not too meaningful. My partner works in a bank - its term end for them - so lots of spreadsheets and reports are being finished - this is that kind of thing? We can draw very little from it?
What do we know - they did a small placing recently - not large enough to achieve anything much really - presumably cash is a bit low. Lots of news due. It seems some scientists are actually using the software (we get that from X). Just long slow journey towards being a bit more commercial. Sorry that's not very rampy is it? Perhaps someone else can do better.
Broker reconciliation I would think.
Do they mean anything?
Can you draw any suggestion from them?
Likewise, this morning's trades - 08:07:48
You'll have noticed that almost all of them were at the same time.
Morning
If we say TB and family have always controlled 30% approximately of the company then they:
Currently own Ā£1m of stock
January 2024 owned Ā£3m of stock
November 2020 high they owned Ā£11m of stock
So you could say they have a paper loss of Ā£10m. Have they sold the company, no. Have they stayed at around 30% holding, yes. Have they taken it private, no.
Has the companyās technology improved in 3 years, I would say most definitely.
This is where we all have to make our own judgment call. Do we believe in the technology or are we worried about TBās shenanigans? If he is so financially astute why didnāt he sell in November 2020. We keep saying he knows far more about what is happening behind the scenes than we do. We also know he said previously he would be judged by the share price within 2 years.
I am not trying to be TBās biggest fan but looking at this logically something must be in the pipeline to keep him interested. So as I see it people can jump ship at a possible loss or we can sit it out for a bit longer and see where this goes. How long, I donāt know? However, I do believe in all the great work KS and her team are doing. That is what I am invested in.
Personally I am nursing a considerable loss and I hate all the shenanigans that are happening but āin IB I trustā and like a few others will stick around until āthe endā.
Just my Friday ramblings, have a good weekend everybody.
Thanks
So many tiny buys today. like a school of tiny fishes.
the kind of people who like to spend 80p on a share, they like IQAI.
why do they like IQAI? who are they? are they even people ? Maybe they are some kind of computer trade from an Austin Powers type figure in a major bank or fund with complex algorithms and billions - well 80p - at their disposal, setting their sights on little old IQAI.
Thank you Tyke68 for sharing relevant information; my thanks also to others, who continuously do the same on this forum.
I have, foolishly as it turns out, held my IQAI investment, through thick and thin, for over two years. I have since realised that any company managed by Mr. Brown is optimal for traders rather than LTIs.
Nevertheless, in this case the products, and quality of technology, upon which the investment case rests is sound enough. The negative side is that competitors are presumably developing similar AI led scanning technology?
My aspiration rests on a major entity deciding to make an offer for the company. In my case 30p would be more than sufficient to realise a very good profit, although I appreciate that potentially, the value created by IB should command a significantly higher buyout offer.
GLALTIs.
More progress on MRI scans
https://apple.news/AoK71NEeqTkeqUICCUtt_ug
Thanks
Max
A nice bidding war for our technology between Google, Microsoft, Elon Musk and anybody else would be quite nice. I wonder if TB has their direct numbers. I think we could all retire nicely then.
Thanks
Fingers crossed Tyke !
Could do with some good news
Max
Not sure if this is positive or negative?
Negative, Google supersede our technology?
Positive, Google helps with our AI or they buy our AI?
Watch this space
Thanks
Dear all just found this update
If we get the PRD designation it looks like we have until 2026 to get approved so we can get the voucher. As always this is my reading of this totally confusing procedure.
ā2024 update: Rare Pediatric Disease PRV program sunset
Under the current provisions in the law, the rare pediatric disease PRV program will begin to sunset after September 30, 2024. Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act states:
(5) TERMINATION OF AUTHORITY.āThe Secretary may not award any priority review vouchers [. . .] after September 30, 2024, unless the rare pediatric disease product applicationā
(A) is for a drug that, not later than September 30, 2024, is designated [. . .] as a drug for a rare pediatric disease; and
(B) is, not later than September 30, 2026, approved under section 505(b)(1) of this Act or section 351(a) of the Public Health Service Act.ā
Come on Mike give us some good news we are all desperate for.
Thanks
Looks like no more sellers - no isa buys either!!
Tempting... wonder if they will let us in!!
-- BB --
Anybody know when the AGM is? Itās cĀ£60 to fly to Jersey for the day from London. Anybody up for it?